Roberson, Mya L. http://orcid.org/0000-0002-9908-910X
Nichols, Hazel B.
Olshan, Andrew F.
Wheeler, Stephanie B.
Reeder-Hayes, Katherine E.
Robinson, Whitney R.
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R36HS027299)
Robert Wood Johnson Foundation
University Cancer Research Fund
Article History
Received: 10 January 2022
Accepted: 3 March 2022
First Online: 14 March 2022
Declarations
:
: Drs. Wheeler and Reeder-Hayes received unrelated grant funding from Pfizer paid to their institution in the past 3 years. The other authors declare that they have no conflict of interest.
: This investigation was approved by the Institutional Review Board (IRB) at the University of North Carolina at Chapel Hill (IRB # 18-3552).
: We received a waiver of informed consent through the University of North Carolina at Chapel Hill IRB. This waiver was received because this is an investigation of secondary data originally collected for other than research purposes. This secondary data analysis represented no more than minimal risk to participants, the waiver did not adversely affect the rights and welfare of participants, and the research could not practicably be carried out without the waiver. There was no direct communication or contact with the participants in this investigation.